Cargando…

New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407

Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Bakhrushina, Elena O., Novozhilova, Elizaveta V., Shumkova, Marina M., Pyzhov, Victor S., Nikonenko, Maria S., Bardakov, Alexander I., Demina, Natalia B., Krasnyuk, Ivan I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379042/
https://www.ncbi.nlm.nih.gov/pubmed/37504387
http://dx.doi.org/10.3390/gels9070508
_version_ 1785079915322802176
author Bakhrushina, Elena O.
Novozhilova, Elizaveta V.
Shumkova, Marina M.
Pyzhov, Victor S.
Nikonenko, Maria S.
Bardakov, Alexander I.
Demina, Natalia B.
Krasnyuk, Ivan I.
Krasnyuk, Ivan I.
author_facet Bakhrushina, Elena O.
Novozhilova, Elizaveta V.
Shumkova, Marina M.
Pyzhov, Victor S.
Nikonenko, Maria S.
Bardakov, Alexander I.
Demina, Natalia B.
Krasnyuk, Ivan I.
Krasnyuk, Ivan I.
author_sort Bakhrushina, Elena O.
collection PubMed
description Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecular weights and some classical gel-forming polymers on the gelation temperature of thermoreversible compositions based on poloxamer 407 in a long-term experiment. The study showed a positive effect of PEG addition with average molecular weights at concentrations of 1.5–2.0%, as well as gelling agents at a concentration below the critical gelation concentration. The proposed rheological test for studying the samples’ adhesion can give an indirect forecast of the composition adhesive rate. Based on the conducted studies, three experimental binary systems based on poloxamer 407 were selected, with the addition of HPMC 0.5%, sodium alginate 0.5%, and PEG 1500 1.5%. These systems are the most promising for the further development of in situ targeted drug delivery systems.
format Online
Article
Text
id pubmed-10379042
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103790422023-07-29 New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407 Bakhrushina, Elena O. Novozhilova, Elizaveta V. Shumkova, Marina M. Pyzhov, Victor S. Nikonenko, Maria S. Bardakov, Alexander I. Demina, Natalia B. Krasnyuk, Ivan I. Krasnyuk, Ivan I. Gels Article Thermosensitive systems based on poloxamer 407 are widely used in targeted drug delivery; however, the stability of the phase transition temperature remains insufficiently studied. This article presents the results of a study on the effect of adding polyethylene glycols (PEG) with different molecular weights and some classical gel-forming polymers on the gelation temperature of thermoreversible compositions based on poloxamer 407 in a long-term experiment. The study showed a positive effect of PEG addition with average molecular weights at concentrations of 1.5–2.0%, as well as gelling agents at a concentration below the critical gelation concentration. The proposed rheological test for studying the samples’ adhesion can give an indirect forecast of the composition adhesive rate. Based on the conducted studies, three experimental binary systems based on poloxamer 407 were selected, with the addition of HPMC 0.5%, sodium alginate 0.5%, and PEG 1500 1.5%. These systems are the most promising for the further development of in situ targeted drug delivery systems. MDPI 2023-06-21 /pmc/articles/PMC10379042/ /pubmed/37504387 http://dx.doi.org/10.3390/gels9070508 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bakhrushina, Elena O.
Novozhilova, Elizaveta V.
Shumkova, Marina M.
Pyzhov, Victor S.
Nikonenko, Maria S.
Bardakov, Alexander I.
Demina, Natalia B.
Krasnyuk, Ivan I.
Krasnyuk, Ivan I.
New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title_full New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title_fullStr New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title_full_unstemmed New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title_short New Biopharmaceutical Characteristics of In Situ Systems Based on Poloxamer 407
title_sort new biopharmaceutical characteristics of in situ systems based on poloxamer 407
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379042/
https://www.ncbi.nlm.nih.gov/pubmed/37504387
http://dx.doi.org/10.3390/gels9070508
work_keys_str_mv AT bakhrushinaelenao newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT novozhilovaelizavetav newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT shumkovamarinam newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT pyzhovvictors newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT nikonenkomarias newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT bardakovalexanderi newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT deminanataliab newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT krasnyukivani newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407
AT krasnyukivani newbiopharmaceuticalcharacteristicsofinsitusystemsbasedonpoloxamer407